Filing Details

Accession Number:
0001728117-23-000086
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-26 16:01:55
Reporting Period:
2023-06-22
Accepted Time:
2023-06-26 16:01:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1728117 Gossamer Bio Inc. GOSS Pharmaceutical Preparations (2834) 475461709
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1867872 Richard Aranda 3013 Science Park Road
San Diego CA 92121
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-22 1,814 $1.29 197,574 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,539 Indirect By family trust
Footnotes
  1. Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
  2. This transaction was executed in multiple trades at prices ranging from $1.285 to 1.29 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.